Do you really know? What are the latest advances in lung cancer treatment?
Oct 27, 2025
Discover the latest breakthroughs in lung cancer treatment, focusing on the promising CheckMate 816 trial. It explores how combining nivolumab with chemotherapy before surgery can significantly delay cancer progression. Learn about the prevalence of lung cancer and the mechanisms behind tumor development. Understand the differences between small cell and non-small cell lung cancers, alongside common treatment methods. The discussion also touches on the future adoption of this innovative therapy and its potential impact on patient care.
AI Snips
Chapters
Transcript
Episode notes
Immunotherapy Boosts Pre-Surgery Outcomes
- The CheckMate 816 trial found adding nivolumab to chemotherapy before surgery extended event-free survival by about 11 months.
- Pathologic complete response occurred in 24% of samples and reduced side effects and surgical complications.
High Mortality Due To Late Diagnosis
- Lung cancer was the third most diagnosed cancer in 2020 but caused about 25% of cancer deaths.
- Late diagnosis drives high mortality because symptoms often appear only at advanced stages.
Two Distinct Lung Cancer Types
- Small cell lung cancer is more aggressive and mainly linked to smoking while non-small cell accounts for most cases.
- Different types respond differently to treatment and require distinct approaches.